Session 10 –New Frontiers in Therapeutics
Date: 24 July (Friday) 09:00 – 10:30 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Dr. Toru Jay Seo is a Senior Director and APAC head of Search & Evaluation, Worldwide Business Development, Chief Business Office of Pfizer Inc. He obtained his PhD in Molecular and Cellular Pathology from Wake Forest University and completed post-doctoral training in cardiovascular and metabolic diseases at Columbia University. He joined the faculty as an assistant professor in Department of Pediatrics at Columbia University Medical Center where he performed independent academic research as well as teaching in the field of lipid metabolism. In 2006, he moved to pursue a R&D career, focusing on target identification and preclinical pharmacology, first with GSK and then with Merck, both in Japan and the US. While at Merck in the US, his responsibilities grew to include project leader, global scientific committee member and Team Lead in Central Pharmacology, and his teams were responsible for preclinical pharmacology studies as well as external collaborations supporting cardiovascular and diabetes therapeutic areas. In 2012, he joined Taisho Pharmaceutical in Tokyo leading efforts in corporate strategy, scientific scouting, academic partnering, and product licensing. Leveraging his unique experience with the combination of academia and industry background, he continues to lead open innovation after joining Pfizer Inc. as a Japan head of External Science and Innovation (ES&I) , executing a plethora of initiatives including biotech venture support, government advisory, new initiatived in the field of digital health and therapeutics. In January of 2019, he became the APAC Lead of Search and Evaluation to oversee the scouting activity of innovative and breakthrough drug candidates and assets in APAC regions. Outside of Pfizer, he is an advisory committee of Osaka University and a visiting lecturer of Waseda Business School, Waseda University. He is also active in engaging as an external counselor and advisors of several biotechs and VC.
Speech title & Synopsis